NYC Dept. Health / Mental Hygiene Screening for Depression
NYC Dept. Health / Mental Hygiene Screening for Depression – designed to ensure the entire US population ranks as depressed
-
-
Drug Warnings: Are They Effective? USA Today
Drug Warnings: Are They Effective? USA Today Tue, 26 Apr 2005 How effective are drug warnings? USA Today reports that experts are unsure. For example, a study in the January issue of Pharmacoepidemiology and Drug Safety focused on Ohio Medicaid claims for Rezulin prescriptions – the diabetes drug had been…
-
Abuses Endangered Veterans in Cancer Drug Experiments – NYT
Abuses Endangered Veterans in Cancer Drug Experiments – NYT Sun, 6 Feb 2005 Paul H. Kornak pleaded guilty to fraud, making false statements and criminally negligent homicide in the death of an Air Force veteran, James DiGeorgio – one of the patients he used as subjects in medical experiments that…
-
FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks
FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks Mon, 29 Aug 2005 Related link: FDA Amicus Curiae–Kallas–claims FDA infallibility pre-empts state safety laws (warning: large 1.6 MB file) A federal judge in Utah has asked the FDA to explain its position as it relates…
-
NIMH Offers Grants to Study SSRI relation to Suicidality – FDA to Examine SSRI- Suicide in Adults
NIMH Offers Grants to Study SSRI relation to Suicidality_FDA to Examine SSRI- Suicide in Adults Mon, 14 Nov 2005 A fifteen year struggle by critics of the drug-centered treatment paradigm in psychiatry is being indirectly validated both by the FDA and the National Institute of Mental Health who are addressing…
-
Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud
Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud Wed, 21 Sep 2005 The latest in a series of fraud settlements, GlaxoSmithKline has agreed to pay $150 million to settle fraud allegations over inflating price of Zorfran and Kytril (nausea drugs) when billing Medicare…
-
Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug
Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug Thu, 29 Sep 2005 Reuters reports that Eli Lilly is adding a Black Box suicide warning to the Strattera label. Strattera has been promoted as a “non stimulant” treatment for ADHD. Since ADHD…
-
Suicide Rate Unchanged in 10 Years–JAMA / AMA Considers Stand Against Warning Labels on Antidepressants
Suicide Rate Unchanged in 10 Years–JAMA / AMA Considers Stand Against Warning Labels on Antidepressants Thu, 9 Jun 2005 A major report in the Journal of the American Medical Association shatters all claims about the effectiveness of antidepressants as a treatment for the prevention of suicide. A comparison of the…
-
Obesity Researcher AdmitsFabricating Data- $3 Mill Fraud in Gov Grants – Boston Globe
Obesity Researcher AdmitsFabricating Data- $3 Mill Fraud in Gov Grants – Boston Globe Fri, 18 Mar 2005 The Boston Globe reports about the worst case of scientific fraud to come to light. Dr. Eric Poehlman, a star among obesity researchers, faces jail time. He overstated the effects of menopause on…
-
Disingenous Remarks from AMA President on Tort Reform – letter BMJ / NYT Test a Lawyer’s Ingenuity
Disingenous Remarks from AMA President on Tort Reform – letter BMJ / NYT Test a Lawyer’s Ingenuity Sun, 6 Mar 2005 Responding to an article in the BMJ about President Bush’s bill to restrict class action suits for medical malpractice-http://bmj.bmjjournals.com/cgi/content/full/330/7490/499-c – the president of the American Medical Association, Dr. John…
-
Lilly Withdraws Duloxetine Application from FDA
Lilly Withdraws Duloxetine Application from FDA Fri, 28 Jan 2005 Eli Lilly and Boeringer Ingelheim have jointly announced that they have recinded their U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence. http://newsroom.lilly.com/ReleaseDetail.cfm?ReleaseID=154081&print=yes Withdrawal of an application from FDA approval process is usually the result of the manufacturer’s…
-
SAMHSA Backs Away From TeenScreen & TMAP
SAMHSA Backs Away From TeenScreen & TMAP Mon, 24 Oct 2005 On October 17, a meeting took place with Charles Currie in Washington DC – with some in attendance by conference call. Currie is the Administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA), the federal agency charged…